Abstract
From the practical point of view of the gastroenterologists and general practitioners there are still some questions awaiting sastifactory and complete answers. Which patients to treat and what therapy to use are the most important for any physician. As far as the first question is concerned patients with duodenal ulcer are most likely to benefit from anti-Helicobacter pylori therapy, mainly in order to prevent the ulcer relapse. Nowdays, many data support the fact that the eradication of H. pylori prevents the recurrence of duodenal ulcer in almost 75% of the patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Pajares, J.M. (1993). Treatment of Helicobacter pylori Infection: Challenges and Future Prospects. In: Pajares, J.M., Peña, A.S., Malfertheiner, P. (eds) Helicobacter pylori and Gastroduodenal Pathology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77486-7_72
Download citation
DOI: https://doi.org/10.1007/978-3-642-77486-7_72
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-77488-1
Online ISBN: 978-3-642-77486-7
eBook Packages: Springer Book Archive